Showing results (21-30 of 312) with videos related to

Sort By:
Pageof 32
Case Reports in Oncological Medicine|October 6, 2025
Isolated Leptomeningeal Carcinomatosis in Urothelial Carcinoma: A Case Report of Positive CSF Cytology With Negative ImagingChristina Lim, Eric Winquist, Mariamma Joseph, et al.
The Canadian Journal of Urology|July 5, 2006
Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancerJonathan I Izawa, Joseph L Chin, Eric Winquist
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer: a systematic review and practice guidelineSebastien Hotte, Tricia Waldron, Christina Canil, et al.
The Canadian Journal of Urology|September 6, 2006
The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trialsScott Berry, Tricia Waldron, Eric Winquist, et al.
Expert Opinion on Therapeutic Targets|December 9, 2004
Therapeutic targets for antimetastatic therapyBenjamin D Hedley, Eric Winquist, Ann F Chambers
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 5, 2018
Late Relapse of Ovarian Germ Cell TumourObaidullah Khan, Eric Winquist, Helen Ettler, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 19, 2012
Consolidative high-dose chemotherapy after conventional-dose chemotherapy as first salvage treatment for male patients with metastatic germ cell tumoursMichel Beausoleil, D Scott Ernst, Larry Stitt, et al.
Investigational New Drugs|October 28, 2010
A phase I study of temsirolimus and metformin in advanced solid tumoursMary J MacKenzie, Scott Ernst, Craig Johnson, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 24, 2016
Validation of a prediction model for avoiding post-chemotherapy retroperitoneal lymphadenectomy in patients with metastatic nonseminomatous germ cell cancerNahid Punjani, Nicholas Power, James J Vanhie, et al.
Reports (MDPI)|January 21, 2026
From MAiD Referral to Targeted Therapy Success: A Case of BRAF-Mutated Anaplastic Thyroid CancerBrett Stubbert, Paul Stewart, Eric Winquist, et al.
Pageof 32